SCHEMBL24309806

SCHEMBL24309806

CN1CCN(c2cccc(Oc3cc(-c4ccccc4C4CCC4)nc(NSc4cnn(C)c4)n3)c2Cl)CC1

nearest known ligand 0.31

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 1/20 0.31
▸ PFKFB3 Q16875 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24309801 0.86 DRD2 (0.31) EGFR
SCHEMBL26807391 0.85 HTR1A (0.37) EGFR
SCHEMBL29566863 0.85 HTR1A (0.37) EGFR
SCHEMBL24310772 0.84 HTR1A (0.33) —
SCHEMBL24310751 0.83 MAP4K1 (0.34) EGFR
SCHEMBL24309803 0.83 DRD3 (0.37) EGFR
SCHEMBL24310478 0.76 BRD4 (0.32) —
SCHEMBL24310709 0.76 DRD2 (0.33) EGFR
SCHEMBL24309230 0.74 EGFR (0.32) EGFR
SCHEMBL24309527 0.73 DRD2 (0.39) EGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022076627-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
Send feedback